AtriCure Rings the Opening Bell
Along with the many accomplishments to celebrate this year, AtriCure visits the Nasdaq MarketSite in Times Square to ring the opening bell and is proud to celebrate its 25th anniversary!
LeAAPS Trial Completes Enrollment
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction (LeAAPS) Clinical Trial has completed enrollment
The Next Generation AtriClip Device
The AtriClip PRO-Mini Device is designed to optimize visualization of the left atrial appendage (LAA) for minimally invasive procedures.
Top Workplaces 2025
Ready to work at a Top Workplace?
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
U.S. NEWS
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission to reduce the global Afib epidemic?
THERAPY INNOVATION
Post-Operative Pain Management: A non-opioid solution
PM-US-0301S-0527-G
© 2025 Atricure, Inc. All Rights Reserved.
AtriCure: Impacting Lives, One Patient at a Time
Duration: 4:5
AtriClip FLEX∙V® Device Animation
Duration: 2:9
AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion
Duration: 3:47
Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices
Duration: 1:25
social media channels to keep updated on the latest at AtriCure.